Galena's Breast Cancer Vaccine Doomed To Fail

LAKE OSWEGO, Oregon (TheStreet) -- Galena Biopharma's breast cancer vaccine NeuVax will fail when results of a phase III clinical trial are eventually announced in three years or so. I can boldy predict NeuVax's failure this far in advance because Galena is making the same mistakes and taking the same sloppy shortcuts that Keryx Pharmaceuticals did with its colon cancer drug perifosine.

Topics:  lake oswego   oregon thestreet     galena biopharma   keryx pharmaceuticals   february   gale   drugs   i   galena   neuvax   click   market   stock   
BING NEWS:
  • Breast cancer patient given 24 months to live has ‘miraculous’ recovery, says God led her to cure
    Tina Willits, now 53, thought she had just two years to live. Today, she is cancer-free — and she wants the world to know about the treatment that saved her.
    12/16/2024 - 8:30 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News